CAS 98319-24-5
:3-oxo-4-aza-5A-androstane-17B-(N-T-butylcarboxamoyl)
- 17β-(N-tert-Butylcarbamoyl)-4-aza-5α-androstan-3-one
- 3-Oxo-4-Aza-5A-Androstane-17B-(N-T-Butyl)Carboxamide
- (4aR,4bS,6aS,7S,9aS,9bS,11aR)-N-tert-butyl-4a,6a-dimethyl-2-oxohexadecahydro-1H-indeno[5,4-f]quinoline-7-carboxamide
- Androstane-N-terbutyl-3-oxo-4-aza-5 alfa-17 beta-carboxamide
- 17-Beta-(N-Butylcarbamoyl)-4-Aza-5-Alpha-Androstan-3-One
- 17β-(t-Butylcarbamoyl)-4-aza-5a-androstan-3-one
- Dihydroproscar
- N-tert-butyl-3-oxo-4-aza-5α-androst-17β-carboxamide
- Dihydro Finasteride
(4AR,4bS,6aS,7S,9aS,9bS,11aR)-N-(tert-butyl)-4a,6a-dimethyl-2-oxohexadecahydro-1H-indeno[5,4-f]quinoline-7-carboxamide
CAS:Formula:C23H38N2O2Purity:98%Color and Shape:SolidMolecular weight:374.56003-Oxo-4-aza-5A-androstane-17-β-(N-tert-butylcarboxamide); 98%
CAS:Formula:C23H38N2O2Purity:(HPLC) ≥ 98.0%Color and Shape:White to off-white powderMolecular weight:374.56Dihydroproscar
CAS:Formula:C23H38N2O2Purity:≥ 95.0% (anhydrous basis)Color and Shape:White to off-white powderMolecular weight:374.56Finasteride EP Impurity A
CAS:Formula:C23H38N2O2Color and Shape:White To Off-White SolidMolecular weight:374.57N-(1,1-Dimethylethyl)-3-oxo-4-aza-5α-androstane-17β-carboxamide (Dihydrofinasteride)
CAS:Controlled ProductFormula:C23H38N2O2Color and Shape:NeatMolecular weight:374.56Dihydro Finasteride
CAS:Impurity Finasteride EP Impurity A
Applications Dihydro Finasteride (Finasteride EP Impurity A) is the reduced product of Finasteride (F342000): a mechanism-based inhibitor of human prostate and skin steroid 5α-reductase. It forms an enzyme-bound NADP-dihydrofinasteride adduct during this inhibitory process.
References Bull, H.G. et al.: Am. J. Chem. Soc., 118, 2359 (1996); Liang, T. et al.: Endocrinol., 117, 571 (1985); Ellsworth, K.P. et al.: J. Steroid Bioche. Mol. Biol., 66, 271 (1998);Formula:C23H38N2O2Color and Shape:Off-WhiteMolecular weight:374.56Dihydroproscar
CAS:Dihydroproscar is a synthetic retinoid that is clinically used to treat benign prostatic hyperplasia (BPH). It has been shown to inhibit the synthesis of 3β-hydroxysteroid, which is necessary for the conversion of testosterone to dihydrotestosterone. Dihydroproscar also has a denaturing effect on proteins and inhibits the in vitro synthesis of DNA and RNA. The second-order rate constant for the reaction of dihydroproscar with ribonucleotides is about 1.4 times faster than that for other retinoids. Dihydroproscar has pharmacokinetic properties that are similar to those of other retinoids, including fatty acids and hydrogen chloride.
Formula:C23H38N2O2Purity:Min. 97 Area-%Color and Shape:PowderMolecular weight:374.56 g/mol3-Oxo-4-aza-5-α-androstane-17-β-N-t-butylcarboxamide
CAS:Formula:C23H38N2O2Purity:98%Color and Shape:SolidMolecular weight:374.569Ref: 4Z-F-0524
Discontinued product









